Rhinathiol Expectorant indications
Rhinathiol Expectorant is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease.
Uses of Rhinathiol Expectorant in details
Rhinathiol Expectorant is used along with other medications as adjunctive therapy to treat conditions of the respiratory tract which causes difficulty in breathing, including chronic obstructive airways disease.
Rhinathiol Expectorant description
Rhinathiol Expectorant is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Rhinathiol Expectorant should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. Rhinathiol Expectorant is produced by alkylation of cysteine with chloroacetic acid.
Rhinathiol Expectorant dosage
Capsule: Adult and Children ≥12 years: 1 capsule. Forte Suspension: Adult and Children ≥12 years: 5 mL (1 tsp). 100 mg/5 mL Pediatric Suspension: Children 8-12 years: 15 mL (3 tsp), 4-7 years: 10 mL (2 tsp), 2-3 years: 5 mL (1 tsp). 200 mg/5 mL Pediatric Suspension: Children 8-12 years: 7.5 mL, 4-7 years: 5 mL, 2-3 years: 2.5 mL. InfantOral Drops:
Infants 1-2 years: 1.5 mL. All doses to be taken orally every 8 hrs.
Rhinathiol Expectorant interactions
mixing Rhinathiol Expectorant with pholcodine linctus causes precipitation of Rhinathiol Expectorant from solution but no information is given on whether this incompatibility is with the pholcodine or some component of the formulation used.
Rhinathiol Expectorant side effects
Capsules, Syrup and Paediatric Syrup:
Immune System Disorders
There have been reports of anaphylactic reactions and fixed drug eruption.
Skin and subcutaneous tissue disorders
There have been reports of skin rashes and allergic skin eruptions.
Capsules and Syrup:
Gastrointestinal disorders
There have been rare reports of gastrointestinal bleeding occurring during treatment with Rhinathiol Expectorant.
Rhinathiol Expectorant contraindications
Adult Syrup: Gastroduodenal ulceration.
Children Syrup: Known hypersensitivity to any of the components of Rhinathiol Expectorant Children Syrup, in particular to parabens. Children <2 years due to risk of worsening airway congestion.
Active ingredient matches for Rhinathiol Expectorant:
| Unit description / dosage (Manufacturer) | Price, USD |
| Syrup; Oral; Carbocisteine 15% | |
List of Rhinathiol Expectorant substitutes (brand and generic names): | |
| Rhinathiol Toux Grasse | |
| Syrup; Oral; Carbocisteine 2% | |
| Rhinatol (Thailand) | |
| Rhinatol 380 mg x 500's | |
| Rhinatol 125 mg/5 mL x 60 mL | |
| Rhinatol 250 mg/5 mL x 60 mL | |
| Rhinatussol (Switzerland) | |
| Rhinatussol Kinder (Switzerland) | |
| Rhinex (Germany, Thailand) | |
| Drops; Nasal; Naphazoline Hydrochloride (Stada) | |
| Rhinex / raspberry flavour 100 mg/5 mL x 60 mL (Stada) | |
| Rhinex 100 mg/5 mL x 1 L (Stada) | |
| Rhinex syr 100 mg/5 mL 1 L x 1's (Stada) | |
| Rhinex syr 100 mg/5 mL / raspberry flavour 60 mL x 1's (Stada) | |
|
sponsored
| |
| Rinatiol (Spain) | |
| Rinatiols (Latvia) | |
| Rinofan (South Africa) | |
| RiteMED Carbocisteine (Philippines) | |
| Robikids (Philippines) | |
| Robikids / orange flavor 250 mg/5 mL x 15 mL (Pfizer Consumer) | |
| Robikids 250 mg/5 mL x 60 mL (Pfizer Consumer) | $ 1.99 |
| Robikids 250 mg/5 mL x 120 mL (Pfizer Consumer) | $ 3.11 |
| Robikids oral susp 250 mg/5 mL / orange flavor 60 mL x 1's (Pfizer Consumer) | $ 2.18 |
| Robikids oral susp 250 mg/5 mL / orange flavor 120 mL x 1's (Pfizer Consumer) | $ 3.39 |
| Romilar Mucolyticum (Belgium) | |
| Rotpunkt Apotheke Mucolyticum (Switzerland) | |
| Rotpunkt Apotheke Mucolyticum Sirup | |
| Syrup; Oral; Carbocisteine 250 mg / 5 ml | |
| S-Carplex (Philippines) | |
| S-Muxine (Philippines) | |
| Santamex (Greece) | |
| Santamex-Expectorant (Greece) | |
| Sawatene (Japan) | |
| SCMC (Malaysia) | |
| SCMC 125 mg/5 mL x 60 mL (Beacons) | |
| SCMC 125 mg/5 mL x 100 mL (Beacons) | |
| Sedotussin Muco (Germany) | |
| Capsule; Oral; Carbocisteine (Ucb) | |
| Granules; Oral; Carbocisteine (Ucb) | |
| Liquid; Oral; Carbocisteine (Ucb) | |
| Siflex (Thailand) | |
| Siflex 375 mg x 10 x 10's (Siam Bheasach) | |
| Siflex 250 mg/5 mL x 60 mL (Siam Bheasach) | |
| Siflex 100 mg/5 mL x 60 mL (Siam Bheasach) | |
| Siflex ped syr 100 mg/5 mL 60 mL x 1's (Siam Bheasach) | |
| Siflex syr 250 mg/5 mL 60 mL x 1's (Siam Bheasach) | |
| Siflex tab 375 mg 10 x 10's (Siam Bheasach) | |
| Sinecod Tosse Fluidificante (Italy) | |
| Sinecosin (Czech Republic) | |
| Sirop des Vosges Expectorant (France) | |
See 916 substitutes for Rhinathiol Expectorant | |
Reviews
The results of a survey conducted on ndrugs.com for Rhinathiol Expectorant are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Rhinathiol Expectorant. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
2 consumers reported useful
Was the Rhinathiol Expectorant drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Useful | 1 | 50.0% | |
| Not useful | 1 | 50.0% | |
Consumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yet11 consumers reported age
| Users | % | ||
|---|---|---|---|
| 30-45 | 4 | 36.4% | |
| 16-29 | 3 | 27.3% | |
| 1-5 | 3 | 27.3% | |
| > 60 | 1 | 9.1% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
